JAZZ
Jazz Pharmaceuticals margins
- Stocks
- Healthcare
- NASDAQ: JAZZ
- Margins
Using the latest TTM figures, Jazz Pharmaceuticals shows a gross margin of 89.1%, an operating margin of 9%, an EBITDA margin of 24.3%, and a net margin of 4.4%. Operating margin had the largest improvement, increasing by 20.9 percentage points, while the other available margins also improved.
JAZZ margin history
Over the last 3 years, Jazz Pharmaceuticals recorded average margins of 88.8% gross, 7.48% operating, 23.71% EBITDA, and 5.43% net. Jazz Pharmaceuticals's current performance shows that gross, operating, and EBITDA margins are above their three-year averages and net margin is below its three-year average.
JAZZ margin expansion
Gross margin expanded by 0.6 percentage points, operating margin by 20.9 percentage points, EBITDA margin by 19.9 percentage points, and net margin by 13.3 percentage points, led by operating margin with an increase of 20.9 percentage points.
JAZZ Gross margin
Across the last 3 years, Jazz Pharmaceuticals's gross margin stood at 88.8%. Compared with its three-year average, Jazz Pharmaceuticals's current gross margin is 89.1% and is 0.3 percentage points above its three-year average. Gross margin was highest at 89.5% in Mar 2024 and lowest at 88% in Mar 2026.
JAZZ Operating margin
Across the last 3 years, Jazz Pharmaceuticals's operating margin averaged 7.48%. As of the latest period, Jazz Pharmaceuticals's current operating margin is 9%, which is 1.5 percentage points above its three-year average. Operating margin was highest at 19.5% in Jun 2026 and lowest at -11.9% in Sep 2025.
JAZZ EBITDA margin
Over the last 3 years, Jazz Pharmaceuticals's EBITDA margin averaged 23.71%. The current EBITDA margin of 24.3% is 0.6 percentage points above its three-year average. During this period, EBITDA margin reached a high of 35.1% in Jun 2026 and a low of 4.4% in Sep 2025.
JAZZ Net margin
Jazz Pharmaceuticals recorded an average net margin of 5.43% across the last 3 years. Jazz Pharmaceuticals's current net margin is 4.4% and is 1 percentage points below its three-year average. Net margin was highest at 20.4% in Jun 2026 and lowest at -9.9% in Jun 2025.
JAZZ margin group comparison
Jazz Pharmaceuticals's gross margin of 89.1% is above the Healthcare sector and the industry average. Compared to its Healthcare sector average of 68.3%, Jazz Pharmaceuticals's gross margin is 30% higher.
JAZZ margin peer comparison
Frequently asked questions
What is Jazz Pharmaceuticals's gross margin?
The current gross margin for JAZZ is 89.1% as of Sep 30, 2026.
What is Jazz Pharmaceuticals's operating margin?
The current operating margin for JAZZ is 9% as of Sep 30, 2026.
What is Jazz Pharmaceuticals's EBITDA margin?
As of Sep 30, 2026, JAZZ has an EBITDA margin of 24.3%.
What is Jazz Pharmaceuticals's net margin?
For the period ending Sep 30, 2026, JAZZ recorded a net margin of 4.4%.
What are the average margins of JAZZ?
Jazz Pharmaceuticals's gross, operating, EBITDA, and net margins averaged 88.8% gross, 7.5% operating, 23.7% EBITDA, and 5.4% net over the last 3 years.
What are the highest historical margins of JAZZ?
Across the 5-year period, JAZZ posted its highest margins at 89.5% gross in Mar 2024, 19.5% operating in Jun 2026, 35.1% EBITDA in Jun 2026, and 20.4% net in Jun 2026.
What are the lowest historical margins of JAZZ?
In the last 5 years, the lowest margins reported by JAZZ were 84.4% gross in Mar 2022, -11.9% operating in Sep 2025, 4.4% EBITDA in Sep 2025, and -13.6% net in Mar 2022.